Intrua Financial, LLC Merck & Co., Inc. Transaction History

Intrua Financial, LLC

$502 Million
Q1 2023

A detailed history of Intrua Financial, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Intrua Financial, LLC holds 4,779 shares of MRK stock, worth $535,630. This represents 0.1% of its overall portfolio holdings.

Number of Shares

4,779

Previous 5,694 16.07%

Holding current value

$535,630

Previous $631,000 19.49%

% of portfolio

0.1%

Previous 0.15%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$102.94 - $114.86 $94,190 - $105,096	-915 Reduced 16.07%	4,779 $508,000
Q4 2022 Jan 20, 2023	SELL	$87.44 - $112.11 $517,557 - $663,579	-5,919 Reduced 50.97%	5,694 $0
Q3 2022 Nov 14, 2022	SELL	$84.53 - $94.96 $625,437 - $702,609	-7,399 Reduced 38.92%	11,613 $1 Million
Q2 2022 Aug 12, 2022	SELL	$83.49 - $94.64 $86,495 - $98,047	-1,036 Reduced 5.17%	19,012 $1.73 Million
Q1 2022 May 11, 2022	SELL	$73.51 - $82.4 $103,649 - $116,184	-1,410 Reduced 6.57%	20,048 $1.65 Million
Q4 2021 Feb 14, 2022	BUY	$72.28 - $90.54 $41,561 - $52,060	575 Added 2.75%	21,458 $1.65 Million
Q3 2021 Oct 28, 2021	BUY	$71.68 - $78.83 $807,618 - $888,177	11,267 Added 117.17%	20,883 $1.7 Million
Q2 2021 Aug 12, 2021	BUY	$70.31 - $77.77 $4,851 - $5,366	69 Added 0.72%	9,616 $723,000
Q1 2021 Apr 30, 2021	BUY	$68.86 - $81.11 $137,720 - $162,220	2,000 Added 26.5%	9,547 $739,000
Q4 2020 Feb 03, 2021	BUY	$71.77 - $79.65 $33,803 - $37,515	471 Added 6.66%	7,547 $617,000
Q3 2020 Nov 16, 2020	SELL	$73.18 - $82.95 $115,404 - $130,812	-1,577 Reduced 18.22%	7,076 $574,000
Q2 2020 Aug 14, 2020	BUY	$70.42 - $80.13 $609,344 - $693,364	8,653 New	8,653 $723,000

Others Institutions Holding MRK

# of Institutions

3,829

Shares Held

1.91B

Call Options Held

13.4M

Put Options Held

10.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $284B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Intrua Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intrua Financial, LLC with notifications on news.

Account

Intrua Financial, LLC Merck & Co., Inc. Transaction History